IPP-203101

N/A

Report date: 2025/10/30 17:46:47
NME

Base Information

Drug NameIPP-203101
Drug Alias NameIPP-203101
ClassificationSmall molecules > Heterocyclic drugs > AntibioticsSmall molecules > Synthetic peptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmupharma Plc
China Registration ClassN/A

Develop Information

Active CompaniesImmupharma Plc
Inactive CompaniesN/A
Active IndicationsStaphylococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A